UBS downgrades Merck to Neutral, cuts price target to $150
UBS downgrades MRK to Neutral from Buy and sets a $150.00 price target.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
UBS downgrades Merck to Neutral from Buy
UBS downgrades MRK to Neutral from Buy, changing its view on the stock; no catalyst was supplied in the alert.